Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Bone and Mineral Metabolism
Published in: Journal of Bone and Mineral Metabolism 5/2022

14-06-2022 | Correction

Correction to: Epidemiology of locomotive syndrome using updated clinical decision limits: 6-year follow-ups of the ROAD study

Authors: Noriko Yoshimura, Toshiko Iidaka, Chiaki Horii, Kanae Mure, Shigeyuki Muraki, Hiroyuki Oka, Hiroshi Kawaguchi, Toru Akune, Hideaki Ishibashi, Takashi Ohe, Hiroshi Hashizume, Hiroshi Yamada, Munehito Yoshida, Kozo Nakamura, Sakae Tanaka

Published in: Journal of Bone and Mineral Metabolism | Issue 5/2022

Login to get access

Excerpt

In the original publication of the article, under the section “Association of LOCOMO stages with the occurrence of disability and mortality”, number (3) was included incorrectly in the following sentence “Logistic regression analysis was used to test the association of LOCOMO stages 1, 2, and 3 with mortality after adjusting for age (+ 1 year), sex (0: men; 1: women), BMI (+ 1 kg/m2), and regional differences (0: mountainous area; 1: coastal area).” and the number is removed in this correction. …
Metadata
Title
Correction to: Epidemiology of locomotive syndrome using updated clinical decision limits: 6-year follow-ups of the ROAD study
Authors
Noriko Yoshimura
Toshiko Iidaka
Chiaki Horii
Kanae Mure
Shigeyuki Muraki
Hiroyuki Oka
Hiroshi Kawaguchi
Toru Akune
Hideaki Ishibashi
Takashi Ohe
Hiroshi Hashizume
Hiroshi Yamada
Munehito Yoshida
Kozo Nakamura
Sakae Tanaka
Publication date
14-06-2022
Publisher
Springer Nature Singapore
Published in
Journal of Bone and Mineral Metabolism / Issue 5/2022
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-022-01349-z

Other articles of this Issue 5/2022

Journal of Bone and Mineral Metabolism 5/2022 Go to the issue

Original Article

Trends in osteoporosis prevalence over a 10-year period in Japan: the ROAD study 2005–2015

Original Article

Relationships between QUS and HR-pQCT, DXA, and bone turnover markers

Original Article

Association of pentosidine and homocysteine levels with number of teeth present in Japanese postmenopausal women

Original Article

Positive association of fasting plasma glucose with bone mineral density in non-diabetic elderly females

Original Article

Fractures within 2 years of an obstetric hospitalization: analysis of nationwide administrative data in Japan

Original Article

Real-world persistence of twice-weekly teriparatide and factors associated with the discontinuation in patients with osteoporosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits